RT Journal Article
SR Electronic
T1 Individuals with Methamphetamine Use Disorder Show Reduced Directed Exploration and Learning Rates Independent of an Aversive Interoceptive State Induction
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.05.17.24307491
DO 10.1101/2024.05.17.24307491
A1 Goldman, Carter M.
A1 Takahashi, Toru
A1 Lavalley, Claire A.
A1 Li, Ning
A1 Taylor, Samuel
A1 Chuning, Anne E.
A1 Hodson, Rowan
A1 Stewart, Jennifer L.
A1 Wilson, Robert C.
A1 Khalsa, Sahib S.
A1 Paulus, Martin P.
A1 Smith, Ryan
YR 2024
UL http://medrxiv.org/content/early/2024/05/21/2024.05.17.24307491.abstract
AB Methamphetamine Use Disorder (MUD) is associated with substantially reduced quality of life. Yet, decisions to use persist, due in part to avoidance of anticipated withdrawal states. However, the specific cognitive mechanisms underlying this decision process, and possible modulatory effects of aversive states, remain unclear. Here, 56 individuals with MUD and 58 healthy comparisons (HCs) performed a decision task, both with and without an aversive interoceptive state induction. Computational modeling measured the tendency to test beliefs about uncertain outcomes (directed exploration) and the ability to update beliefs in response to outcomes (learning rates). Compared to HCs, those with MUD exhibited less directed exploration and slower learning rates, but these differences were not affected by aversive state induction. These results suggest novel, state-independent computational mechanisms whereby individuals with MUD may have difficulties in testing beliefs about the tolerability of abstinence and in adjusting behavior in response to consequences of continued use.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis project was funded by National Institute of General Medical Sciences (P20GM121312 [R.S. and M.P.P.]) and the Laureate Institute for Brain Research.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:WCG Institutional Review Board of the Laureate Institute for Brain Research gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.